Health Condition 1: E116- Type 2 diabetes mellitus with other specified complications
Conditions
Interventions
Intervention1: Lycopodium: After case taking and repertorization, if the patient fits the inclusion criteria, they will be enrolled in the study. Lycopodium in any potency will be
administered as per
Sponsors
Dr Pem M
Eligibility
Inclusion criteria
Inclusion criteria: 1. Participants with HbA1C levels more than 6.5%. 2. Participants taking conventional medicine for Type 2 Diabetes Mellitus. 3. Cases of both genders between 25-70 years of age. 4. Participants with Lycopodium as indicated remedy after repertorisation.
Exclusion criteria
Exclusion criteria: 1. Pregnant women and lactating mothers. 2. Cases with known underlying uncontrollable systemic illness (except hypertension).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The likelihood ratio between The symptoms and the effectiveness of Lycopodium in Type 2 Diabetes Mellitus.Timepoint: Study period 1.5 years | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Changes in the HbA1C, FBS and PPBS levels will be assessed at the baseline and at the conclusion of the study. 2. Changes in A Systemic Result Evaluation Method score.Timepoint: HbA1C and systemic result evaluation method score will be assessed once in 3 months, FBS and PPBS will be assessed once a month. | — |
Countries
India
Contacts
Public ContactDr Vinitha E R
National Homoeopathy Research Institute in Mental Health
Outcome results
None listed